Literature DB >> 15255852

The use of recombinant factor VIIa in severe postpartum hemorrhage.

Shmuel Segal1, Iftah Y Shemesh, Rima Blumental, Boris Yoffe, Neri Laufer, David Mankuta, Moshe Mazor, Shifra Zohar, Eyal Schiff, Uri Martinovitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15255852     DOI： 10.1111/j.0001-6349.2004.00501.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  5 in total

Review 1.  Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.

Authors:  Ulla Hedner; Nikolai C Brun
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

Review 2.  Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.

Authors:  Anthony E Pusateri; Myung S Park
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

3.  Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.

Authors:  Sandro B Rizoli; Kenneth D Boffard; Bruno Riou; Brian Warren; Philip Iau; Yoram Kluger; Rolf Rossaint; Michael Tillinger
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 4.  Haemostatic monitoring during postpartum haemorrhage and implications for management.

Authors:  C Solomon; R E Collis; P W Collins
Journal:  Br J Anaesth       Date:  2012-10-16       Impact factor: 9.166

5.  Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.

Authors:  Yoram Kluger; Bruno Riou; Rolf Rossaint; Sandro B Rizoli; Kenneth David Boffard; Philip Iau Tsau Choong; Brian Warren; Michael Tillinger
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.